This Is the Only Chinese Stock I Would Buy Right Now
111 (NASDAQ: YI) is a severely undervalued telepharmacy that is rapidly expanding across all of China. The stock trades at less than 0.4 times revenue with a market cap of less than $500 million, despite showing no signs of stalling. It is quite obvious investors are heavily discounting its potential as part of a broad sell-off in Chinese stocks due to fears of regulatory crackdowns.
But there's a key reason that won't happen to 111. Let's look at why the company is unique and what makes it a value stock that investors can count on for price appreciation.
Image source: Getty Images.
Source Fool.com
